Professor Mark Lawler is Professor of Digital Health and Chair in Translational Cancer Genomics at Queen’s University Belfast
He is Co-lead of the All Island Cancer Research Institute (AICRI), Scientific Director of DATA-CAN, the UK’s Health Data Research Hub for Cancer and Chair of the International Cancer Benchmarking Partnership, which captures and compares cancer outcomes globally. He is Chair of the recently-published Lancet Oncology European Groundshot Commission, the most comprehensive analysis of cancer research in Europe ever, which reimagines cancer research and its implementation across Europe.
Mark has a strong commitment to patient-centered research and addressing cancer inequalities. He was architect of the European Cancer Patient’s Bill of Rights, launched in the European Parliament (World Cancer Day). He received the 2018 European Health Award, a prestigious award for partnerships that yield real health impact in Europe. His pioneering work on Covid-19 and cancer received the Royal College of Physicians Excellence in Patient Care Award and the European Communique Award, which recognised the use of data to enhance cancer services and effect policy change.
He leads the European Cancer Organisation’s European Cancer Pulse, which captures data intelligence to inform mitigation of cancer inequalities. In 2021, Mark received the Irish Association for Cancer Research’s Outstanding Contribution to Cancer Research award, for his pioneering work on cancer research and care on the island of Ireland. In 2022, he and his team won the HDR-UK Impact of the Year Award for providing the crucial intelligence to inform a policy change for treating colorectal cancer.
